We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+2.45%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$525B
AUM Growth
+$91.7B
Cap. Flow
+$84.3B
Cap. Flow %
16.06%
Top 10 Hldgs %
21.31%
Holding
3,738
New
263
Increased
2,391
Reduced
822
Closed
116

Sector Composition

Rank Sector Weight
1 Technology 21.36%
2 Financials 10.66%
3 Healthcare 9.68%
4 Consumer Discretionary 8.35%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SACH
3526
Sachem Capital Corp
SACH
$37.1M
$42.3K ﹤0.01%
16,351
ATYR
3527
aTyr Pharma
ATYR
$47.4M
$41.6K ﹤0.01%
26,689
HGBL icon
3528
Heritage Global
HGBL
$41.7M
$41.3K ﹤0.01%
16,791
GRTS
3529
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$41.1K ﹤0.01%
66,565
-200,640
-75% -$170K
ABAT icon
3530
American Battery Technology Co
ABAT
$280M
$40.8K ﹤0.01%
32,662
+134
+0.4% +$185
REFR icon
3531
Research Frontiers
REFR
$13.6M
$40.2K ﹤0.01%
21,870
XPL icon
3532
Solitario Resources
XPL
$66.3M
$39.7K ﹤0.01%
44,899
ELDN icon
3533
Eledon Pharmaceuticals
ELDN
$255M
$39.6K ﹤0.01%
14,987
LTRX icon
3534
Lantronix
LTRX
$223M
$39.5K ﹤0.01%
11,128
PFIE
3535
DELISTED
Profire Energy, Inc
PFIE
$39.3K ﹤0.01%
27,669
DMAC icon
3536
DiaMedica Therapeutics
DMAC
$341M
$39.1K ﹤0.01%
13,251
PDSB icon
3537
PDS Biotechnology
PDSB
$37.4M
$38.9K ﹤0.01%
13,278
-63,925
-83% -$205K
CNTY icon
3538
Century Casinos
CNTY
$32.9M
$38.2K ﹤0.01%
13,792
-62,870
-82% -$182K
KZR
3539
DELISTED
Kezar Life Sciences
KZR
$38K ﹤0.01%
6,336
-16,313
-72% -$124K
OPRT icon
3540
Oportun Financial
OPRT
$262M
$37.8K ﹤0.01%
13,044
VANI icon
3541
Vivani Medical
VANI
$109M
$37.8K ﹤0.01%
30,017
OPTN
3542
DELISTED
OptiNose
OPTN
$37.6K ﹤0.01%
2,412
-11,109
-82% -$186K
RLMD icon
3543
Relmada Therapeutics
RLMD
$540M
$37.5K ﹤0.01%
12,505
MCHX icon
3544
Marchex
MCHX
$78M
$37.4K ﹤0.01%
24,313
BEAT icon
3545
Heartbeam
BEAT
$28.2M
$37.4K ﹤0.01%
14,543
SPRO icon
3546
Spero Therapeutics
SPRO
$68.9M
$37.1K ﹤0.01%
28,565
BCOV
3547
DELISTED
Brightcove, Inc.
BCOV
$36.8K ﹤0.01%
15,530
-98,970
-86% -$194K
SND icon
3548
Smart Sand
SND
$179M
$36.8K ﹤0.01%
17,439
DHX icon
3549
DHI Group
DHX
$177M
$36.8K ﹤0.01%
17,605
-89,600
-84% -$208K
BGFV
3550
DELISTED
Big 5 Sporting Goods
BGFV
$36.6K ﹤0.01%
12,375
-49,178
-80% -$162K

Similar funds

Charles Schwab's Q2 2024 Portfolio in Review

As of Q2 2024, Charles Schwab held 3,738 positions worth $525B, up 21% from $433B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Charles Schwab deployed $84.3B of net new capital in Q2 2024, opening 263 new positions and adding to 2,391 existing holdings. Its largest new stake was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Texas Instruments, an estimated $367M trimmed.

  • Charles Schwab's largest Q2 2024 buy was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
  • Charles Schwab added most to Schwab Fundamental US Large Company Index ETF in Q2 2024, an estimated $8.54B increase.
  • Charles Schwab's biggest Q2 2024 reduction was Texas Instruments, cutting an estimated $367M.
  • Charles Schwab fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $335M.
  • Charles Schwab's ten largest holdings make up 21% of its $525B portfolio in Q2 2024.
  • Charles Schwab opened 263 new positions and closed 116 in Q2 2024.
  • Charles Schwab's portfolio value rose 21% quarter-over-quarter to $525B.

Based on Charles Schwab's 13F filing for Q2 2024, filed 12 Aug 2024.